{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:20:04Z","timestamp":1777504804696,"version":"3.51.4"},"reference-count":63,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T00:00:00Z","timestamp":1644364800000},"content-version":"vor","delay-in-days":373,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jacc.2020.12.009","type":"journal-article","created":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T13:12:43Z","timestamp":1612271563000},"page":"609-619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Coenzyme Q10 for Patients With Cardiovascular Disease"],"prefix":"10.1016","volume":"77","author":[{"given":"Albert E.","family":"Raizner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A.","family":"Qui\u00f1ones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2020.12.009_bib1","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0006-3002(57)90457-2","article-title":"Isolation of a quinone from beef heart mitochondria","volume":"25","author":"Crane","year":"1957","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jacc.2020.12.009_bib2","series-title":"Coenzyme Q10 market size by application (pharmaceuticals, dietary supplements, cosmetics), industry analysis report, regional outlook, growth potential, competitive market share and forecast, 2019\u20132016","author":"Ahuja","year":"2019"},{"key":"10.1016\/j.jacc.2020.12.009_bib3","series-title":"Highlights in Ubiquinone Research","first-page":"77","article-title":"The classical mobile carrier function of lipophilic quinones in the osmochemistry of electron-driven proton translocation","author":"Mitchell","year":"1990"},{"key":"10.1016\/j.jacc.2020.12.009_bib4","first-page":"11","article-title":"Coenzyme Q saturation kinetics of mitochondrial enzymes: theory, experimental aspects and biomedical implications","volume":"Vol 6","author":"Lenaz","year":"1991"},{"key":"10.1016\/j.jacc.2020.12.009_bib5","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1007\/BF00226842","article-title":"Ubiquinol: an endogenous antioxidant in aerobic organisms","volume":"71","author":"Ernster","year":"1993","journal-title":"Clin Investig"},{"key":"10.1016\/j.jacc.2020.12.009_bib6","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/10715760600617843","article-title":"Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics","volume":"40","author":"Bhagavan","year":"2006","journal-title":"Free Radic Res"},{"key":"10.1016\/j.jacc.2020.12.009_bib7","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/BF02544535","article-title":"Discharge of newly-synthesized dolichol and ubiquinone with lipoproteins to rat liver perfusate and to the bile","volume":"24","author":"Elmberger","year":"1989","journal-title":"Lipids"},{"key":"10.1016\/j.jacc.2020.12.009_bib8","first-page":"109","article-title":"Relative bioavailability of coenzyme Q10 formulations in human subjects","volume":"68","author":"Chopra","year":"1998","journal-title":"Int J Vitam Nutr Res"},{"key":"10.1016\/j.jacc.2020.12.009_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/cpdd.73","article-title":"Comparison study of plasma Coenzyme Q10 levels in healthy subjects supplemented with ubiquinol versus ubiquinone","volume":"3","author":"Langsjoen","year":"2014","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.jacc.2020.12.009_bib10","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1046\/j.1440-6047.2001.00244.x","article-title":"Similar therapeutic serum levels attained with emulsified and oil-based preparations of coenzyme Q10","volume":"10","author":"Lyon","year":"2001","journal-title":"Asia Pac J Clin Nutr"},{"key":"10.1016\/j.jacc.2020.12.009_bib11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.nut.2018.05.020","article-title":"Bioavailability of coenzyme Q10 supplements depends on carrier lipids and solubilization","volume":"57","author":"Lopez-Lluch","year":"2018","journal-title":"Nutrition"},{"key":"10.1016\/j.jacc.2020.12.009_bib12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0925-4439(95)00028-3","article-title":"Biochemical, physiological and medical aspects of ubiquinone functions","volume":"1271","author":"Ernster","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jacc.2020.12.009_bib13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/0003-9861(92)90511-T","article-title":"Distribution and redox state of ubiquinones in rat and human tissues","volume":"295","author":"Aberg","year":"1992","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.jacc.2020.12.009_bib14","first-page":"28","article-title":"Coenzyme Q10: a review of essential functions and clinical trials","volume":"25","author":"Fuke","year":"2000","journal-title":"US Pharmacist"},{"key":"10.1016\/j.jacc.2020.12.009_bib15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s40256-017-0251-2","article-title":"Does coenzyme Q10 supplementation mitigate statin-associated muscle symptoms? Pharmacological and methodological considerations","volume":"18","author":"Taylor","year":"2018","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.jacc.2020.12.009_bib16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/biof.5520180212","article-title":"The clinical use of HMG CoA-reductase inhibitors and the associated depletion of coenzyme Q10. A review of animal and human publications","volume":"18","author":"Langsjoen","year":"2003","journal-title":"Biofactors"},{"key":"10.1016\/j.jacc.2020.12.009_bib17","first-page":"87","article-title":"Determination of coenzyme Q10, \u03b1-tocopherol and cholesterol in biological samples b coupled-column liquid chromatography with coulometric and ultraviolet detection","volume":"425","author":"Edlund","year":"1988","journal-title":"J\u00a0Chromatogr"},{"key":"10.1016\/j.jacc.2020.12.009_bib18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0021-9673(01)94626-6","article-title":"Quantitative determination of vitamin E and oxidized and reduced coenzyme Q by HPLC with in-line ultraviolet and electrochemical detection","volume":"385","author":"Lang","year":"1987","journal-title":"J\u00a0Chromatogr"},{"key":"10.1016\/j.jacc.2020.12.009_bib19","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1373\/clinchem.2005.054643","article-title":"Determination of coenzyme Q10 status in blood mononuclear cells, skeletal muscle, and plasma by HPLC with di-propoxy-coenzyme Q10 as an internal standard","volume":"51","author":"Duncan","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacc.2020.12.009_bib20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0009-8981(03)00137-2","article-title":"Plasma coenzyme Q10 reference intervals, but not redox status, are affected by gender and race in self-reported healthy adults","volume":"332","author":"Miles","year":"2003","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jacc.2020.12.009_bib21","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0002-9149(90)90824-K","article-title":"Long-term efficacy and safety of coenzyme Q10 therapy for idiopathic dilated cardiomyopathy","volume":"65","author":"Langsjoen","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2020.12.009_bib22","first-page":"28","article-title":"Coenzyme Q10: efficacy, safety, and use","volume":"4","author":"Jones","year":"2002","journal-title":"Int J Integr Med"},{"key":"10.1016\/j.jacc.2020.12.009_bib23","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/sj.ejcn.1601464","article-title":"Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes","volume":"56","author":"Hodgson","year":"2002","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.jacc.2020.12.009_bib24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/sj.jhh.1002138","article-title":"Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials","volume":"21","author":"Rosenfeldt","year":"2007","journal-title":"J\u00a0Human Hypertens"},{"key":"10.1016\/j.jacc.2020.12.009_bib25","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/S0140-6736(94)90736-6","article-title":"Reduced effect of warfarin caused by ubidecarenone","volume":"344","author":"Spigset","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2020.12.009_bib26","first-page":"1868","article-title":"Effect of Coenzyme Q10 and Ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebo-controlled cross-over trial","volume":"165","author":"Engelsen","year":"2003","journal-title":"Ugeskr Laeger"},{"key":"10.1016\/j.jacc.2020.12.009_bib27","first-page":"533","article-title":"Bioenergetics in clinical medicine. III. Inhibition of coenzyme Q10-enzymes by clinically used anti-hypertensive drugs","volume":"12","author":"Kishi","year":"1975","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"10.1016\/j.jacc.2020.12.009_bib28","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/CIRCRESAHA.116.309115","article-title":"Decline in cardiovascular mortality: possible causes and implications","volume":"120","author":"Mensah","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2020.12.009_bib29","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/eurheartj\/ehn554","article-title":"Modeling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002","volume":"30","author":"Bjorck","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2020.12.009_bib30","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2125.2003.02044.x","article-title":"Professional athletes suffering from familiar hypercholesterolemia rarely tolerate statin treatment because of muscular problems","volume":"57","author":"Sinzinger","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2020.12.009_bib31","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jacl.2013.03.001","article-title":"Predictors of statin adherence, switching, and discontinuation in the USAGE survey: understanding the use of statins in America and gaps in patient education","volume":"7","author":"Wei","year":"2013","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.jacc.2020.12.009_bib32","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.jacc.2016.12.036","article-title":"Statin intolerance and risk of coronary heart events and all-cause mortality following myocardial infarction","volume":"69","author":"Serban","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.12.009_bib33","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1093\/eurheartj\/ehz458","article-title":"Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: a nationwide population-based cohort study in France","volume":"40","author":"Giral","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2020.12.009_bib34","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jacc.2012.09.036","article-title":"Simvastatin effects on skeletal muscle: relation to decreased mitochondrial function and glucose intolerance","volume":"61","author":"Larsen","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.12.009_bib35","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.amjcard.2006.12.063","article-title":"Effect of Coenzyme Q10 on myopathic symptoms in patients treated with statins","volume":"99","author":"Caso","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2020.12.009_bib36","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1515\/jbcpp-2016-0149","article-title":"Addition of omega-3 fatty acid and coenzyme Q10 to statin therapy in patients with combined dyslipidemia","volume":"28","author":"T\u00f3th","year":"2017","journal-title":"J\u00a0Basic Clin Physiol Pharmacol"},{"key":"10.1016\/j.jacc.2020.12.009_bib37","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.amjcard.2012.04.026","article-title":"Effect of Coenzyme Q10 supplementation on statin-induced myalgias","volume":"110","author":"Bookstaver","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2020.12.009_bib38","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.atherosclerosis.2014.12.016","article-title":"A\u00a0randomized trial of coenzyme Q10 in patients with confirmed statin myopathy","volume":"238","author":"Taylor","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2020.12.009_bib39","doi-asserted-by":"crossref","first-page":"581","DOI":"10.7326\/0003-4819-137-7-200210010-00009","article-title":"Statin associated myopathy with normal creatine kinase levels","volume":"137","author":"Phillips","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2020.12.009_bib40","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.mayocp.2014.08.021","article-title":"Effects of Coenzyme Q10 on statin-induced myopathy","volume":"90","author":"Banach","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2020.12.009_bib41","article-title":"Effects of Coenzyme Q10 on statin-induced myopathy: an updated meta-analysis of randomized clinical trials","volume":"2","author":"Qu","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2020.12.009_bib42","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s13530-017-0338-9","article-title":"Evaluation of cytochrome c level and mitochondrial dysfunction biomarkers of Oryctolagus cunnicus liver exposed to Chlorpyrifos","volume":"9","author":"Toualbia","year":"2017","journal-title":"Toxicol Environ Health Sci"},{"key":"10.1016\/j.jacc.2020.12.009_bib43","doi-asserted-by":"crossref","first-page":"206","DOI":"10.12968\/bjnn.2018.14.5.206","article-title":"Organophosphate poisoning and coenzyme Q10: an overview","volume":"14","author":"Mantle","year":"2018","journal-title":"Br J Neurosci Nurs"},{"key":"10.1016\/j.jacc.2020.12.009_bib44","article-title":"The effect of organophosphate exposure on neuronal cell coenzyme Q10 Status","author":"Turton","year":"2020","journal-title":"Neurochem Res"},{"key":"10.1016\/j.jacc.2020.12.009_bib45","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1162\/NECO_a_00659","article-title":"Coenzyme Q10 benefits symptoms in Gulf War veterans: results of a randomized double-blind study","volume":"26","author":"Golomb","year":"2014","journal-title":"Neural Comput"},{"key":"10.1016\/j.jacc.2020.12.009_bib46","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0735-1097(02)01721-7","article-title":"Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure","volume":"39","author":"Tsutsui","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.12.009_bib47","first-page":"209","article-title":"Function of coenzyme Q in the cell: some biochemical and physiological properties","volume":"44","author":"Rauchov\u00e1","year":"1995","journal-title":"Physiol Res"},{"key":"10.1016\/j.jacc.2020.12.009_bib48","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1073\/pnas.82.3.901","article-title":"Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q10","volume":"82","author":"Folkers","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2020.12.009_bib49","series-title":"Biomedical and Clinical Aspects of Coenzyme Q.","first-page":"3","article-title":"Transfer of exogenous coenzyme Q10 to the inner membrane of heart mitochondria in rats.","author":"Nakamura","year":"1989"},{"key":"10.1016\/j.jacc.2020.12.009_bib50","first-page":"1579","article-title":"Coenzyme-Q10 [in Japanese]","volume":"4","author":"Hashiba","year":"1972","journal-title":"Heart (Japanese)"},{"key":"10.1016\/j.jacc.2020.12.009_bib51","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1073\/pnas.82.12.4240","article-title":"Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and crossover trial with coenzyme Q10","volume":"82","author":"Langsjoen","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2020.12.009_bib52","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3945\/ajcn.112.040741","article-title":"Effect of coenzyme Q\u2081\u2080 supplementation on heart failure: a meta-analysis","volume":"97","author":"Fontino","year":"2013","journal-title":"Am J Clin Nutr"},{"issue":"Suppl 1","key":"10.1016\/j.jacc.2020.12.009_bib53","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1016\/j.ihj.2018.01.031","article-title":"Coenzyme Q10 in the treatment of\u00a0heart failure: a systematic review of systematic reviews","volume":"70","author":"Jafari","year":"2018","journal-title":"Indian Heart J"},{"key":"10.1016\/j.jacc.2020.12.009_bib54","first-page":"641","article-title":"The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial","volume":"2","author":"Mortensen","year":"2014","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2020.12.009_bib55","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.amjcard.2004.07.121","article-title":"Effect of atorvastatin on left ventricular diastolic function and ability of coenzyme Q10 to reverse that dysfunction","volume":"94","author":"Silver","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2020.12.009_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/807084","article-title":"Physiologic basis and pathophysiologic implications of the diastolic properties of the cardiac muscle","volume":"2010","author":"Ferreira-Martins","year":"2010","journal-title":"J\u00a0Biomed Biotechnol"},{"key":"10.1016\/j.jacc.2020.12.009_bib57","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2165\/0129784-200808060-00004","article-title":"Statin adverse effects. A review of the literature and evidence for a mitochondrial mechanism","volume":"8","author":"Golomb","year":"2008","journal-title":"Cardiovasc Drugs"},{"key":"10.1016\/j.jacc.2020.12.009_bib58","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7812\/TPP\/18.257","article-title":"Statin-associated cardiomyopathy responds to statin withdrawal and administration of Coenzyme Q10","volume":"23","author":"Langsjoen","year":"2019","journal-title":"Perm J"},{"key":"10.1016\/j.jacc.2020.12.009_bib59","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owen","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.12.009_bib60","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/CIRCULATIONAHA.111.080770","article-title":"Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction. Prevalence, therapies and outcomes","volume":"126","author":"Steinberg","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.12.009_bib61","first-page":"273","article-title":"Bioenergetics in clinical medicine: studies on coenzyme Q10 and essential hypertension","volume":"11","author":"Yamagami","year":"1975","journal-title":"Res Comm Dhem Path Pharmacol"},{"key":"10.1016\/j.jacc.2020.12.009_bib62","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1023\/A:1007764616025","article-title":"Randomized, double-blind placebo-controlled trial of coenzyme Q10 in patients with acute myocardial infarction","volume":"12","author":"Singh","year":"1998","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jacc.2020.12.009_bib63","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1023\/A:1023408031111","article-title":"Effect of coenzyme Q10 on risk of atherosclerosis in patients with recent myocardial infarction","volume":"246","author":"Singh","year":"2003","journal-title":"Mol Cell Biochem"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109720379985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109720379985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:37:58Z","timestamp":1760017078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109720379985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0735109720379985"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2020.12.009","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coenzyme Q10 for Patients With Cardiovascular Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2020.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2020.09.619","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2020.09.617","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2020.11.056","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2020.11.060","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}